Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
EBioMedicine ; 8: 184-194, 2016 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-27428429

RESUMO

Fanconi Anemia (FA) is a genetic disorder characterized by elevated cancer susceptibility and pro-inflammatory cytokine production. Using SLX4(FANCP) deficiency as a working model, we questioned the trigger for chronic inflammation in FA. We found that absence of SLX4 caused cytoplasmic DNA accumulation, including sequences deriving from active Long INterspersed Element-1 (LINE-1), triggering the cGAS-STING pathway to elicit interferon (IFN) expression. In agreement, absence of SLX4 leads to upregulated LINE-1 retrotransposition. Importantly, similar results were obtained with the FANCD2 upstream activator of SLX4. Furthermore, treatment of FA cells with the Tenofovir reverse transcriptase inhibitor (RTi), that prevents endogenous retrotransposition, decreased both accumulation of cytoplasmic DNA and pro-inflammatory signaling. Collectively, our data suggest a contribution of endogenous RT activities to the generation of immunogenic cytoplasmic nucleic acids responsible for inflammation in FA. The additional observation that RTi decreased pro-inflammatory cytokine production induced by DNA replication stress-inducing drugs further demonstrates the contribution of endogenous RTs to sustaining chronic inflammation. Altogether, our data open perspectives in the prevention of adverse effects of chronic inflammation in tumorigenesis.


Assuntos
Citocinas/metabolismo , Anemia de Fanconi/complicações , Anemia de Fanconi/genética , Regulação da Expressão Gênica , Mediadores da Inflamação/metabolismo , Elementos Nucleotídeos Longos e Dispersos , Neoplasias/etiologia , Neoplasias/metabolismo , Linhagem Celular , Citoplasma , Dano ao DNA , DNA de Cadeia Simples/genética , DNA de Cadeia Simples/metabolismo , Anemia de Fanconi/imunologia , Anemia de Fanconi/metabolismo , Humanos , Interferons/biossíntese , Recombinases/deficiência , Recombinases/genética , Recombinases/metabolismo , Retroelementos/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...